Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Île-de-France258
A. Krivine6
Île-de-France Sauf A. Krivine" 253
A. Krivine Sauf Île-de-France" 1
Île-de-France Et A. Krivine 5
Île-de-France Ou A. Krivine 259
Corpus10482
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
001093 O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France]Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis
001B01 B. Rousseau [France] ; P. Loulergue ; O. Mir ; A. Krivine ; S. Kotti ; E. Viel ; T. Simon ; A. De Gramont ; F. Goldwasser ; O. Launay ; C. TournigandImmunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.
002077 B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France]Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
002078 A. Kostianovsky [France] ; P. Charles [France] ; J.-F. Alves [France] ; M. Goulet [France] ; C. Pagnoux [France] ; V. Le Guern [France] ; L. Mouthon [France] ; A. Krivine [France] ; P. Villiger [France, Suisse] ; O. Launay [France] ; L. Guillevin [France]Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients
002D42 A. Mathian [France] ; H. Devilliers [France] ; A. Krivine [France] ; N. Costedoat-Chalumeau [France] ; J. Haroche [France] ; D. Boutin-Le Thi Huong [France] ; B. Wechsler [France] ; B. Hervier [France] ; M. Miyara [France] ; N. Morel [France] ; N. Le Corre [France] ; L. Arnaud [France] ; J. C. Piette [France] ; L. Musset [France] ; B. Autran [France] ; F. Rozenberg [France] ; Z. Amoura [France]Factors Influencing the Efficacy of Two Injections of a Pandemic 2009 Influenza A (H1N1) Nonadjuvanted Vaccine in Systemic Lupus Erythematosus

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021